Latest Active Biotech News & Updates

See the latest news and media coverage for Active Biotech. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Active Biotech

Biotech company developing cancer and eye disease treatments

activebiotech.com
Headquarters
Lund, Sweden
Founded year
1998
Company type
Public company
Number of employees
2–20

Latest news about Active Biotech

Company announcements

  • Active Biotech

    Active Biotech publishes LION study results

    The phase I study shows topical laquinimod penetrates the eye's posterior segment, is well-tolerated, supporting development for inflammatory eye diseases.

  • Active Biotech

    Active Biotech invites shareholders to AGM

    The meeting occurs on May 20, 2026, in Lund. Proposals include board re-elections, reverse share split 1:100, and share issue authorization. No dividend proposed.

  • Active Biotech

    Active Biotech publishes preclinical data on tasquinimod

    Tasquinimod improves erythropoiesis and bone health in MDS model via collaboration with Dr. Manja Wobus. It supports MDS as expansion opportunity.

  • Active Biotech

    Active Biotech announces Annual Report 2025 availability

    The report is digitally available at www.activebiotech.com. CEO Helén Tuvesson highlights focus on tasquinimod studies and laquinimod business development.

Unlock all announcements with a

Media coverage

  • Dagens industri

    Active Biotech minskar förlusten

    Forskningsbolaget Active Biotech redovisar ett rörelseresultat på -9,1 miljoner kronor för det fjärde kvartalet 2025 (-10,3).

  • London Stock Exchange

    Active Biotech announces outcome in the rights issue

    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN...

  • The Globe and Mail

    Active Biotech Secures US Patent for Tasquinimod Formulation

    Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and...

  • Nyheter24

    Active Biotech acquires patent rights for tasquinimod in combination therapy

    The research company Active Biotech has entered into an exclusive license agreement with the American Wistar Institute of Anatomy and Biology. It appears from a press release. The license agreement covers the global...

Unlock all articles with a

Never miss news about Active Biotech

Track Active Biotech and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Active Biotech competitors & trending companies

Browse news for competitors to Active Biotech and other trending companies.